174 related articles for article (PubMed ID: 33098494)
1. A systematic review of health state utility values for thyroid cancer.
Houten R; Fleeman N; Kotas E; Boland A; Lambe T; Duarte R
Qual Life Res; 2021 Mar; 30(3):675-702. PubMed ID: 33098494
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of health state utility values in metastatic non-small cell lung cancer with a focus on previously treated patients.
Paracha N; Abdulla A; MacGilchrist KS
Health Qual Life Outcomes; 2018 Sep; 16(1):179. PubMed ID: 30208899
[TBL] [Abstract][Full Text] [Related]
3. A systematic literature review of health state utility values in head and neck cancer.
Meregaglia M; Cairns J
Health Qual Life Outcomes; 2017 Sep; 15(1):174. PubMed ID: 28865475
[TBL] [Abstract][Full Text] [Related]
4. Mapping EORTC-QLQ-C30 to EQ-5D-3L in patients with colorectal cancer.
Marriott ER; van Hazel G; Gibbs P; Hatswell AJ
J Med Econ; 2017 Feb; 20(2):193-199. PubMed ID: 27676291
[TBL] [Abstract][Full Text] [Related]
5. EQ-5D-5L and SF-6D Utility Measures in Symptomatic benign Thyroid Nodules: Acceptability and Psychometric Evaluation.
Wong CKH; Lang BHH; Yu HMS; Lam CLK
Patient; 2017 Aug; 10(4):447-454. PubMed ID: 28224296
[TBL] [Abstract][Full Text] [Related]
6. Mapping EORTC QLQ-C30 and QLQ-MY20 to EQ-5D in patients with multiple myeloma.
Proskorovsky I; Lewis P; Williams CD; Jordan K; Kyriakou C; Ishak J; Davies FE
Health Qual Life Outcomes; 2014 Mar; 12():35. PubMed ID: 24618388
[TBL] [Abstract][Full Text] [Related]
7. Differential Psychometric Properties of EuroQoL 5-Dimension 5-Level and Short-Form 6-Dimension Utility Measures in Low Back Pain.
Cheung PWH; Wong CKH; Cheung JPY
Spine (Phila Pa 1976); 2019 Jun; 44(11):E679-E686. PubMed ID: 30475342
[TBL] [Abstract][Full Text] [Related]
8. Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS.
Svedbom A; Borgström F; Hernlund E; Ström O; Alekna V; Bianchi ML; Clark P; Curiel MD; Dimai HP; Jürisson M; Uusküla A; Lember M; Kallikorm R; Lesnyak O; McCloskey E; Ershova O; Sanders KM; Silverman S; Tamulaitiene M; Thomas T; Tosteson ANA; Jönsson B; Kanis JA
Qual Life Res; 2018 Mar; 27(3):707-716. PubMed ID: 29235059
[TBL] [Abstract][Full Text] [Related]
9. A structured review of health utility measures and elicitation in advanced/metastatic breast cancer.
Hao Y; Wolfram V; Cook J
Clinicoecon Outcomes Res; 2016; 8():293-303. PubMed ID: 27382319
[TBL] [Abstract][Full Text] [Related]
10. Comparison of generic, condition-specific, and mapped health state utility values for multiple myeloma cancer.
Rowen D; Young T; Brazier J; Gaugris S
Value Health; 2012 Dec; 15(8):1059-68. PubMed ID: 23244808
[TBL] [Abstract][Full Text] [Related]
11. A hybrid modelling approach for eliciting health state preferences: the Portuguese EQ-5D-5L value set.
Ferreira PL; Antunes P; Ferreira LN; Pereira LN; Ramos-Goñi JM
Qual Life Res; 2019 Dec; 28(12):3163-3175. PubMed ID: 31201730
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Health State Utility Measures in Patients With Head and Neck Cancer.
Noel CW; Lee DJ; Kong Q; Xu W; Simpson C; Brown D; Gilbert RW; Gullane PJ; Irish JC; Huang SH; O'Sullivan B; Goldstein DP; de Almeida JR
JAMA Otolaryngol Head Neck Surg; 2015 Aug; 141(8):696-703. PubMed ID: 26204439
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the performance of algorithms mapping EORTC QLQ-C30 onto the EQ-5D index in a metastatic colorectal cancer cost-effectiveness model.
Franken MD; de Hond A; Degeling K; Punt CJA; Koopman M; Uyl-de Groot CA; Versteegh MM; van Oijen MGH
Health Qual Life Outcomes; 2020 Jul; 18(1):240. PubMed ID: 32690011
[TBL] [Abstract][Full Text] [Related]
14. EuroQOL-5D-3L does not adequately map quality-of-life deterioration in severely affected patients with epilepsy.
Willems LM; Knake S; Rosenow F; Reese JP; Conradi N; Strzelczyk A
Epilepsy Behav; 2022 Feb; 127():108554. PubMed ID: 35063789
[TBL] [Abstract][Full Text] [Related]
15. Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey.
Longworth L; Yang Y; Young T; Mulhern B; Hernández Alava M; Mukuria C; Rowen D; Tosh J; Tsuchiya A; Evans P; Devianee Keetharuth A; Brazier J
Health Technol Assess; 2014 Feb; 18(9):1-224. PubMed ID: 24524660
[TBL] [Abstract][Full Text] [Related]
16. Mapping the EORTC QLQ-C30 onto the EQ-5D-3L: assessing the external validity of existing mapping algorithms.
Doble B; Lorgelly P
Qual Life Res; 2016 Apr; 25(4):891-911. PubMed ID: 26391884
[TBL] [Abstract][Full Text] [Related]
17. Estimating an exchange rate between the EQ-5D-3L and ASCOT.
Stevens K; Brazier J; Rowen D
Eur J Health Econ; 2018 Jun; 19(5):653-661. PubMed ID: 28623464
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life in rheumatoid arthritis: Systematic review and meta-analysis of EuroQoL (EQ-5D) utility scores from Asia.
Haridoss M; Bagepally BS; Natarajan M
Int J Rheum Dis; 2021 Mar; 24(3):314-326. PubMed ID: 33486900
[TBL] [Abstract][Full Text] [Related]
19. Health state utility values associated with advanced gastric, oesophageal, or gastro-oesophageal junction adenocarcinoma: a systematic review.
Carter GC; King DT; Hess LM; Mitchell SA; Taipale KL; Kiiskinen U; Rajan N; Novick D; Liepa AM
J Med Econ; 2015; 18(11):954-66. PubMed ID: 26212479
[TBL] [Abstract][Full Text] [Related]
20. EQ-5D-3L health state utility values in transfusion-dependent thalassemia patients in Malaysia: a cross-sectional assessment.
Shafie AA; Chhabra IK; Wong JHY; Mohammed NS
Health Qual Life Outcomes; 2021 Jan; 19(1):10. PubMed ID: 33413416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]